Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

CMV vaccine elicits humoral and cellular immune responses in animal models

Oct. 9, 2015

Mixed Hantaan/Puumala virus DNA vaccine shows safety and immunogenicity

Oct. 9, 2015

Genocea reports durability data from 6-month analysis of phase II GEN-003 trial

Oct. 9, 2015

Bristol-Myers Squibb introduces NS5B inhibitors

Oct. 8, 2015

FDA grants priority review to Daklinza supplemental NDAs

Oct. 8, 2015

ContraVir reports preliminary data for tenofovir prodrug in HBV

Oct. 7, 2015

VIS-410 shows activity and reduced duration of symptoms in phase IIa challenge study

Oct. 7, 2015

Blood cytokine biomarker signature detects tuberculosis and identifies dormant/active forms

Oct. 7, 2015

Bristol-Myers Squibb introduces NS5B inhibitors

Oct. 6, 2015

IAPs show promise for the treatment of M. tuberculosis and M. avium infections

Oct. 6, 2015

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...